Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is a hematologic malignancy arising from precursors of the lymphoid lineage. Conventional cytotoxic chemotherapies have resulted in high cure rates of up to 90% in pediatric ALL, but the outcomes for adult patients remain suboptimal with 5-year survival rates of on...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefazi, Mehrdad, Litzow, Mark R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467350/
https://www.ncbi.nlm.nih.gov/pubmed/31360093
http://dx.doi.org/10.2147/BLCTT.S170351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467350/
https://www.ncbi.nlm.nih.gov/pubmed/31360093
http://dx.doi.org/10.2147/BLCTT.S170351

Ejemplares similares